Range
2.2 - 2.31
Vol / Avg.
2.1M/2M
Div / Yield
-
52 Wk
1.43 - 4.13
Mkt Cap
213.7M
Payout Ratio
-
Open
2.27
P/E
-
EPS
-0.26
Shares
96.7M
Outstanding
96.7M
Total Float
74.7M
Benzinga - Dec 3, 2021, 8:13AM
Benzinga - Aug 5, 2021, 5:55PM
load more
Sector: Health Care.Industry: Biotechnology
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-03-16
REV
Q3 2021Est.ActualSurprise
EPS-0.260
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

CTI BioPharma Questions & Anwsers

Q

How do I buy CTI BioPharma (CTIC) stock?

A

You can purchase shares of CTI BioPharma (NASDAQ: CTIC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CTI BioPharma's (CTIC) competitors?

Q

What is the target price for CTI BioPharma (CTIC) stock?

A

The latest price target for CTI BioPharma (NASDAQ: CTIC) was reported by Needham on December 1, 2021. The analyst firm set a price target for 5.00 expecting CTIC to rise to within 12 months (a possible 126.24% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for CTI BioPharma (CTIC)?

A

The stock price for CTI BioPharma (NASDAQ: CTIC) is $2.21 last updated Fri Jan 21 2022 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does CTI BioPharma (CTIC) pay a dividend?

A

There are no upcoming dividends for CTI BioPharma.

Q

When is CTI BioPharma (NASDAQ:CTIC) reporting earnings?

A

CTI BioPharma’s $Q4 earnings are confirmed for after-market on March 16, 2022.

Q

Is CTI BioPharma (CTIC) going to split?

A

There is no upcoming split for CTI BioPharma.

Q

What sector and industry does CTI BioPharma (CTIC) operate in?

A

CTI BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.